skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Vascular dementia: Pharmacological treatment approaches and perspectives

(3344) Views  (784) Full article downloads

Authors: Andrius Baskys, Anthony C Hou

Published Date October 2007 Volume 2007:2(3) Pages 327 - 335
DOI: http://dx.doi.org/10.2147/CIA.S

Andrius Baskys1,3, Anthony C Hou2

1Department of Psychiatry and Human Behavior; 2Program in Geriatrics, University of California at Irvine, Irvine, California; 3Memory Disorders Program, VA Health Care System Long Beach, Long Beach, California, USA

Abstract: Vascular dementia is a common condition for which there are no effective approved pharmacological treatments available. Absence of effective treatments creates a difficult situation for those suffering from the disease, their caregivers, and healthcare providers. This review will address our current understanding of the mechanisms of nerve cell damage due to ischemia and summarize available clinical trial data on several commonly used compounds including memantine, donepezil, galantamine, rivastigmine, nimodipine, hydergine, nicergoline, CDPcholine, folic acid, as well as such nonpharmacological approaches as validation therapy.

Keywords: vascular dementia, excitotoxicity, treatment, NMDA, memantine, donepezil, galantamine, rivastigmine, nimodipine, hydergine, nicergoline, CDP-choline, folic acid